FDA Approved: GABAPENTIN — Supplemental Application (Advagen Pharma Ltd)

View source ↗

Summary

FDA approved a supplemental application for gabapentin submitted by Advagen Pharma Ltd under the existing ANDA. This action updates the regulatory status of the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Postherpetic Neuralgia

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

SUPPL AP for GABAPENTIN (GABAPENTIN)